Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Novozymes A/S    NZYM B   DK0060336014

NOVOZYMES A/S (NZYM B)
Mes dernières consult.
Most popular
Report
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Copenhagen
10/16/2017 10/17/2017 10/18/2017 10/19/2017 10/20/2017 Date
337.1(c) 325(c) 327.7(c) 326.6(c) 327.1(c) Last
492 565 544 817 384 466 537 025 531 166 Volume
+2.03% -3.59% +0.83% -0.34% +0.15% Change
More quotes
Financials ( DKK)
Sales 2017 14 591 M
EBIT 2017 4 083 M
Net income 2017 3 145 M
Debt 2017 1 909 M
Yield 2017 1,29%
Sales 2018 15 157 M
EBIT 2018 4 264 M
Net income 2018 3 292 M
Debt 2018 2 178 M
Yield 2018 1,40%
P/E ratio 2017 30,82
P/E ratio 2018 28,92
EV / Sales2017 5,76x
EV / Sales2018 5,57x
Capitalization 82 186 M
More Financials
Company
Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms.Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile, and wastewater solutions.The... 
Sector
Commodity Chemicals
Calendar
10/25 | 08:00amEarnings Release
More about the company
Surperformance© ratings of Novozymes A/S
Trading Rating : Investor Rating :
More Ratings
Latest news on NOVOZYMES A/S
10/16 TRANSACTIONS UNDER NOVOZYMES’ : As of October 13, Novozymes has purchased..
10/09 TRANSACTIONS UNDER NOVOZYMES’ : As of October 6, Novozymes has purchased ..
10/07 NOVOZYMES A/S : SALEM Novozymes buys two buildings Novozymes Biologicals buys 2 ..
10/07 NOVOZYMES A/S : buys two buildings
10/02 TRANSACTIONS UNDER NOVOZYMES’ : As of September 29, Novozymes has purchas..
09/28 NOVOZYMES A/S : Patent Issued for Polypeptides Having Dextranase Activity and Po..
09/28 NOVOZYMES A/S : Patent Issued for Alpha-Amylases and Polynucleotides Encoding Sa..
09/25 NOVOZYMES A/S : Transactions under Novozymes’ stock buyback program
09/25 TRANSACTIONS UNDER NOVOZYMES’ : As of September 22, Novozymes has purchas..
09/23 NOVOZYMES A/S : Launches initiatives to find solutions for global problems
More news
Sector news : Commodity Chemicals - NEC
10/20DJLINDE : More Than Half of Shares Tendered in Praxair Offer
10/18 ORICA : Advent to sell 45 percent stake in Spanish explosives firm Maxam - sourc..
10/18DJAKZONOBEL : Correction to Akzo Nobel 3Q Earnings Article
10/18DJAKZO NOBEL SHAREHOLDERS 'LEANING TOW : Ceo
10/18 European shares rise as third-quarter earnings roll in, Catalonia weighs on I..
More sector news : Commodity Chemicals - NEC
Latest Tweets
10/18Novozymes launches new enzymatic solution to help detergent producers in emer.. 
10/16Novozymes launches open innovation initiative HelloScience  
09/29ICYMI: Novozymes launches HelloScience to foster scientific collaboration
1
09/28Novozymes launches HelloScience to foster scientific collaboration
2
09/24$NVZMY - Novozymes A/S - #NVZMY Rating Lowered to Hold at Zacks Investment Re.. 
More tweets
Qtime:28
News from SeekingAlpha
09/18 Nordic Dividend Royals
08/11 Novozymes' (NVZMF) CEO Peder Holk Nielsen on Q2 2017 Results - Earnings Call ..
08/11 Novozymes A/S 2017 Q2 - Results - Earnings Call Slides
08/11 Novozymes A/S reports 1H results
04/26 Novozymes' (NVZMF) CEO Peder Holk Nielsen on Q1 2017 Results - Earnings Call ..
Chart NOVOZYMES A/S
Duration : Period :
Novozymes A/S Technical Analysis Chart | NZYM B | DK0060336014 | 4-Traders
Technical analysis trends NOVOZYMES A/S
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 18
Average target price 279  DKK
Spread / Average Target -15%
EPS Revisions
Managers
NameTitle
Peder Holk Nielsen President & Chief Executive Officer
Jørgen Buhl Rasmussen Chairman
Thomas Videbaek COO, Executive VP-Research, Innovation & Supply
Carl Erik Mathias Uhlén Independent Director
Lars Bo Køppler Director
Sector and Competitors
1st jan.Capitalization (M$)
NOVOZYMES A/S34.58%13 018
AIR LIQUIDE-1.56%52 934
SHIN-ETSU CHEMICAL CO LTD20.88%41 728
PRAXAIR, INC.19.81%40 942
LYONDELLBASELL INDUSTRIES NV14.55%39 161
GIVAUDAN15.92%20 284